Alnylam Pharma (ALNY) Posts Wider than Expected Q3 Loss of 31c/Share

November 5, 2012 4:19 PM

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) reported Q3 EPS of ($0.31) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found